Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kaneka Medix is a Japanese medical device company within the Kaneka group focused on the development, manufacture, and commercialization of interventional and blood purification products. Its portfolio includes neurovascular embolization coils, PTCA and PTA balloon catheters, aspiration and penetration catheters, microcatheters, exchange catheters, and extracorporeal blood purification systems such as Liposorber, Selesorb, and Lixelle. The company appears to operate as a commercial-stage device business rather than a therapeutics developer, serving cardiovascular, neurovascular, dialysis, and related hospital markets. Kaneka Medix is part of Kaneka Corporation's healthcare business and supports global medical-device activities through affiliated Kaneka medical businesses in regions including the United States and Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kaneka Medix.